PHARMACOKINETIC PROFILE OF TETRAPRENYLTOLUQUINONE AFTER SINGLE-DOSE ORAL ADMINISTRATION IN MALE MICE
DOI:
https://doi.org/10.22159/ijap.2023.v15s1.02Keywords:
Tetraprenyltoluquinone (TPTQ), Pharmacokinetic, Oral, Blood plasma, High performance liquid chromatography (HPLC)Abstract
Objective: The aim of this study to investigate pharmacokinetic profile of tetraprenyltoluquinone (TPTQ) in male mice’s blood plasma.
Methods: A single dose of 800 mg/kg carried by Virgin Coconut Oil (VCO) was given orally where VCO only also administered as a control. Bloods were collected from vena jugularis after 0, ½, ¾, 1, 1½, 2, 3, 4, 6, 8, 12, and 24 h. The TPTQ levels in plasma were analyzed using High-Performance Liquid Chromatography (HPLC) following pre-treatment to induce protein precipitation.
Results: The formed pharmacokinetic profile follows the two-compartment model where TPTQ levels increase during the absorption phase and form a biphasic pattern after it decrease. The results showed the pharmacokinetic parameters had Cmax value of 154.92±19.55 µg/ml at tmax of 1.117 h with AUC0-∞ of 1067.59 µg. h/ml. Other parameters were also obtained such as ka = 1.448±0.17 h-1, α = 0.511±0.07 h-1, ke = 0.057±0.02 h-1, t½ absorption = 0.483±0.05 h, t½ elimination = 12.131±0.55 h, Vd/F = 5284.79±629.49 ml, dan Cl/F = 751.84±53.85 ml/h.
Conclusion: The pharmacokinetic profile of TPTQ administered orally show that TPTQ absorbed rapidly, eliminated slowly, and also distributed to peripheral tissues.
Downloads
References
Sharifi Rad J, Ozleyen A, Boyunegmez Tumer T, Oluwaseun Adetunji C, El Omari N, Balahbib A. Natural products and synthetic analogs as a source of antitumor drugs. Biomolecules. 2019;9(11). doi: 10.3390/biom9110679, PMID 31683894.
Atanasov AG, Zotchev SB, Dirsch VM, International Natural Product Sciences Taskforce, Supuran CT. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200-16. doi: 10.1038/s41573-020-00114-z, PMID 33510482.
Susanti M, Ibrahim S, Harahap Y, Dachriyanus DD. Comparison between high-performance thin layer chromatography and high-performance liquid chromatography methods for determination of rubraxanthone in the stem bark extract of garcinia cowa Roxb. Pharmacogn J. 2018;10(6s):s42-7. doi: 10.5530/pj.2018.6s.8.
Wahyuni FS, Byrne LT, Dachriyanus, Dianita R, Jubahar J, Lajis NH. A new ring-reduced tetraprenyltoluquinone and a prenylated xanthone from garcinia cowa. Aust J Chem. 2004;57(3). doi: 10.1071/CH03175.
Wahyuni FS, Hui LS, Stanslas J, Lajis NH, Dachriyanus. Tetraprenyltoluquinone, an anticancer compound from Garcinia cowa roxb induce cell cycle arrest on H460 non-small lung cancer cell line. Int J Pharm Sci Rev Res. 2015;32(2).
Wahyuni FS, Hui LS, Stanslas J, Lajis NHJ. In vivo study of tetraprenyltoluquinone, an anticancer compound from Garcinia cowa Roxb. J Young Pharm. 2017;9(2):296-8. doi: 10.5530/jyp.2017.9.58.
Wahyuni FS, Israf Ali DA, Lajis NH. Anti-inflammatory activity of isolated compounds from the stem bark of Garcinia cowa Roxb. Pharmacogn J. 2016;9(1):55-7. doi: 10.5530/pj.2017.1.10.
Hefni D, Wahyuni FS, Dharma S, Dachriyanus FR, Fadhilah R. In vitro effect of tetraprenyltoluquinone on normal human leukocyte cell. Adv Health Sci Res 2nd International Conference on Contemporary Science and Clinical Pharmacy. 2021. doi: 10.2991/ahsr.k.211105.022.
Susanti M, Darmianti R, Harahap Y, Itam A, Hamidi D. Single dose oral pharmacokinetic profile rubraxanthone in mice. Heliyon. 2022;8(3):e09104. doi: 10.1016/j.heliyon.2022.e09104, PMID 35342834.
Zheng MC, Tang WT, Yu LL, Qian XJ, Ren J, Li JJ. Preclinical pharmacokinetics and bioavailability of oxypeucedanin in rats after single intravenous and oral administration. Molecules. 2022 Jun 1;27(11). doi: 10.3390/molecules27113570, PMID 35684506.
Sabilla AS. Optimasi dan validasi metode analisis tetrapreniltoluquinone (TPTQ) dalam plasma menggunakan kromatografi cair kinerja tinggi. Univ Andalas; 2022.
Rahmi S, Dan ES, Haro G. The giving effects of virgin coconut oil on profile pharmacokinetics diclofenac sodium. Int J PharmTech Res. 2016;9(5).
Hughes NC, Bajaj N, Fan J, Wong EY. Assessing the matrix effects of hemolyzed samples in bioanalysis. Bioanalysis. 2009;1(6):1057-66. doi: 10.4155/bio.09.91, PMID 21083074.
Shargel L, Yu A. Applied biopharmaceutics and pharmacokinetics. 7th ed. New York: McGraw-Hill Education; 2016.
Han YR, Lee PI, Pang KS. Finding T max and C max in multi-compartmental models. Drug Metab Dispos. 2018;46(11):1796-804. doi: 10.1124/dmd.118.082636.
Vertzoni M, Augustijns P, Grimm M, Koziolek M, Lemmens G, Parrott N. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: an UNGAP review. Eur J Pharm Sci. 2019;134:153-75. doi: 10.1016/j.ejps.2019.04.013, PMID 30991092.
Rich GT, Buchweitz M, Winterbone MS, Kroon PA, Wilde PJ. Towards an understanding of the low bioavailability of quercetin: A study of its interaction with intestinal lipids. Nutrients. 2017;9(2). doi: 10.3390/nu9020111, PMID 28165426.
Notari RE. Biopharmaceutics and clinical pharmacokinetics. Biopharm Clin Pharmacokinet. 2017.
Sano Y, Tadano K, Kikuchi K, Kaneko K, Yuzuriha T. Pharmacokinetic characterization of menaquinone-4 in dogs by sensitive HPLC determination. J Nutr Sci Vitaminol (Tokyo). 1993;39(6):555-66. doi: 10.3177/jnsv.39.555, PMID 8006712.
Tadano K, Yuzuriha T, Sato T, Fujita T, Shimada K, Hashimoto K. Identification of menaquinone-4 metabolites in the rat. J Pharmacobiodyn. 1989;12(10):640-5. doi: 10.1248/ bpb1978.12.640, PMID 2630633.
Sano Y, Tadano K, Kaneko K, Kikuchi K, Yuzuriha T. Metabolic fate of menaquinone-4 in dogs. (I). Absorption, distribution, metabolism and excretion after a single oral administration. Drug Metab Pharmacokinet. 1997;12(1):48-57. doi: 10.2133/dmpk.12.48.
Ito S. Pharmacokinetics 101. Paediatr Child Health. 2011;16(9):535-6. doi: 10.1093/pch/16.9.535, PMID 23115489.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
